ATAI — AtaiBeckley Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 2081043 ·
Last close
$4.29
Market Cap
$1.58B
52W High
$5.51
52W Low
$3.27
ADV30
6,757,341
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 954,000 | — | -30,159,000 | -29,782,000 | 264,877,000 | 43,102,000 | 66,098,000 |
| Dec 2025 | 1,066,000 | — | -39,353,000 | -544,813,000 | 292,723,000 | 85,300,000 | 70,722,000 |
| Sep 2025 | 749,000 | — | -28,407,000 | -61,074,000 | 239,820,000 | 30,402,000 | 79,912,000 |
| Jun 2025 | 719,000 | — | -25,245,000 | -27,729,000 | 189,204,000 | 61,940,000 | 45,279,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-102,675,000
Investing CF
$-109,127,000
Financing CF
$269,481,000
CapEx
$-10,868,000
Dividends Paid
—
Buybacks
$-4,468,000
EPS Diluted TTM
$-2.30
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,360,254,000
Inventory
—
Receivables
$14,427,000
ST Investments
$170,740,000
EBIT TTM
$-658,687,000
Pretax Income TTM
$-659,849,000
Interest Exp TTM
$1,162,000
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,488,000
EBITDA
$-120,710,000
Free Cash Flow
—
Enterprise Value
$1,315,389,952
Total Cash
$230,767,008
Total Debt
$2,000,000
Shares Out
368,166,674
Trailing EPS
$-2.84
Book Value
$0.56
ROE
-378.0%
ROA
-33.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,089,000 | -113,347,000 | -660,047,000 | 292,723,000 | 70,722,000 | — | -102,675,000 |
| Dec 2024 | 308,000 | -102,166,000 | -149,269,000 | 159,387,000 | 42,833,000 | — | -82,437,000 |
| Dec 2023 | 314,000 | -123,026,000 | -40,224,000 | 293,478,000 | 49,162,000 | — | -84,118,000 |
| Dec 2022 | 233,000 | -144,430,000 | -152,385,000 | 305,441,000 | 39,675,000 | — | -104,467,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.46
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| QURE | uniQure N.V. | $1.59B | $25.15 | — |
| GHRS | GH Research PLC | $1.59B | $23.15 | — |
| DMRA | Damora Therapeutics, Inc. | $1.59B | $25.89 | — |
| ABCL | AbCellera Biologics Inc. | $1.62B | $5.29 | — |
| ARDX | ARDELYX, INC. | $1.54B | $6.25 | — |
News headlines (Yahoo Finance, 1h cache)
AtaiBeckley (ATAI) Reports Q1 Financial Results
2026-05-22 18:43 · Yahoo
A Look At AtaiBeckley (ATAI) Valuation As Share Price Momentum And DCF Signal Differ
2026-05-16 00:22 · Yahoo
AtaiBeckley clinical pipeline advances toward multiple late-stage data catalysts, Jefferies says
2026-05-13 17:06 · Yahoo
AtaiBeckley targets Q2 start for Phase 3 depression trial as pipeline advances
2026-05-12 13:22 · Yahoo
AtaiBeckley Reports First Quarter 2026 Financial Results and Provides Program and Business Update
2026-05-12 12:00 · Yahoo
AtaiBeckley (ATAI) Reports Positive Phase 2a Results for Social Anxiety Treatment EMP-01
2026-05-10 04:00 · Yahoo
Does AtaiBeckley’s (ATAI) EMP-01 Data Hint At A Scalable MDMA Therapy Platform?
2026-05-01 15:19 · Yahoo
These 3 Psychedelic Stocks Activated After Trump's Executive Order
2026-04-27 15:15 · Yahoo
AtaiBeckley wins OVID Health Silver Award for patient partnership in psychedelic trials
2026-04-27 12:22 · Yahoo
AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research
2026-04-27 08:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.